Fair Pharmacies for Federal Employees Act of 2025

S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779; Patients Before Monopolies Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3822; Break Up Big Medicine Act S. 4189; INSLUN Act of 2026 S. 5586; Ensuring Accurate Payments to Specialty Pharmacies Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services H.R. 9645; Health Care Price Certainty for All Americans Act H.R. 10369; Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)

Client expense: $3,203,049 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE

H.R. 1287, Fix FEDVIP Age Act H.R. 1597, Compassion for Vulnerable and Struggling Workers Act H.R. 1670, Family Building FEHB Fairness Act S. 797, The Family Building FEHB Fairness Act H.R. 2193, FEHB Protection Act of 2025 H.R. 4409, Fair Pharmacies for Federal Employees Act of 2025 H.R. 4648, Access to Fertility Treatment and Care Act S. 2408, Access to Fertility Treatment and Care Act H.R. 5127, PrEP and PEP are Prevention Act H.R. 6610, Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] H.R. 8731, Federal Employee Short-Term Disability Insurance Act of 2026 H.R. 9448, Federal Workforce Reproductive Rights Protection Act H.R. 9941, Right to IVF Act of 2026

Client expense: $310,000 · Firm income: Not reported

S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 4323/ H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 S. 2355/H.R. 5582; Patients Deserve Price Tags Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779; Patients Before Monopolies Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 1095; Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act S. 1096; Preserve Access to Affordable Generics and Biosimilars Act S. 1097; Interagency Patent Coordination and Improvements Act of 2025 S. 1414; Expedited Access to Biosimilars Act S. 2617; Reducing Drug Prices for Seniors Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S. 3349; PBM Disclosure Act S. 3549; PBM Fiduciary, Accountability, Integrity, and Reform Act S. 3822; Break Up Big Medicine Act S. 4189; INSLUN Act of 2026 H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4570; Interagency Patent Coordination and Improvements Act of 2025 H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 6837; To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services oSec. 6702- Full Rebate Pass Through to Plans H.R. 7895; PBM Kickback Prohibition Act H.R. 8324; Great American Healthcare Plan H.R. 9228; Health Data Access, Transparency, and Affordability Act of 2026 H.R. 9486; Health Data Access, Transparency and Affordability Act H.R. 9117; Clear Healthcare Expense Cost Knowledge Act H.R. 9393; Lower Cost, More Transparency Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)

S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779; Patients Before Monopolies Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3822; Break Up Big Medicine Act S. 4189; INSLUN Act of 2026 H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)

Client expense: $3,282,990 · Firm income: Not reported

Issues related to employer, small group and individual insurance markets. H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act H.R. 5433 - The Patients Over Profits Act S. 2836 - The Patients Over Profits Act H.R. 4409 - The Fair Pharmacies for Federal Employees Act of 2025 H.R. 6703, Lower Healthcare Premiums for All Americans Act H.R. 6610, The Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] S. 3822, Break Up Big Medicine Act S. 4509, The Patients Before Monopolies Act

Client expense: $3,570,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1177/S. 492, Improve & Enhance the Work Opportunity Tax Credit Act H.R. 3552/S. 1843, Second Chance Reauthorization Act of 2025 H.R. 4386, Apprenticeship Data Value Improvements to Create Employment (ADVICE) Act H.R. 4409, Streamlining Timely Apprenticeship Registration and Transparency (START) Act H.R. 4424, Securing Help for Involuntary Employment Loss and Displacement (SHIELD) Act H.R. 5408/S. 844, Faster Labor Contracts Act H.R. 6453, ADA 30 Days to Comply Act H.R. 8183, Modernizing Access to Talents, Credentials, and Hiring (MATCH) Act H.R. 8210, A Stronger Workforce for America Act H.R. 8624, Workforce Apprenticeship Growth and Education Support Act H.R. 8714, Skill Savings Account Act H.R. 9224/S. 2828, Child Care Modernization Act S. 4016, Stop Unemployment Fraud Act S. 4071, Child Care Tax Benefit Outreach and Assistance Act S. 4360, INSIGHT Act S. 4746, A bill to provide that certain discriminatory conduct by covered platforms shall be unlawful, and for other purposes Draft legislation titled Ensuring Workers Get PAID Act Draft legislation titled Fair and Open Competition Act Draft legislation titled Protecting the Right to Organize (PRO) Act Nominations of James Macy to serve on the National Labor Relations Board OSHA Notice of Proposed Rulemaking Concerning Heat Injury and Illness Prevention in Outdoor and Indoor Settings (89 Fed. Reg. 70,698-70,699, August 30, 2024) Final OSHA rulemaking on Worker Walkaround Representative Designation Process (89 Fed. Reg. 22,558-22,601, April 1, 2024) Proposed Rulemaking, Wage and Hour Division Employee or Independent Contractor Status Under the Fair Labor Standards Act, Family and Medical Leave Act, and Migrant and Seasonal Agricultural Worker Protection Act (91 Fed. Reg. 9,932-9,976, February 27, 2026) Proposed Rulemaking, Wage and Hour Division Joint Employer Status Under the Fair Labor Standards Act, Family and Medical Leave Act, and Migrant and Seasonal Agricultural Worker Protection Act (91 Fed. Reg. 21,878, April 23, 2026) Various issues relating to unemployment insurance; reforms to the Fair Labor Standards Act (P.L. 75-178); antitrust and consumer protection law grounded in economic analysis; domestic and international antitrust policy; FTC enforcement, agency transparency and reform, and policy and practices related to the agencys authority; duration of FTC consent orders; authority under the Federal Trade Commission Act Sections 5, 13(b), and 19; FTC rulemaking authority and procedure under Federal Trade Commission Act Section 18; FTC rulemakings related to rental fees, delivery fees, and negative options; changes to the FTCs Hart-Scott-Rodino Antitrust Improvements Act merger filing rule; Robinson-Patman Act-related policy and enforcement matters; enforcement of the antitrust laws regarding conduct and mergers; contract terms and their relationship to competition, particularly relating to worker non-compete clauses and exclusive contracts; regulation of digital platforms, including legislation such as AICOA and OAMA; concerns related to Protecting Americans Data from Foreign Adversaries Act (P.L. 118-50); workforce development; career and technical education; education savings accounts; second chance hiring; International Labor Organization and the international labor conference; apprenticeships; child care; vacancies at the National Labor Relations Board

Protect Our Letter Carriers Act (H.R. 1065/S. 463) Federal Retirement Fairness Act (H.R. 1522) Anti-privatization resolution (H.Res. 70/S.Res. 147) Postal Service retirement funds investment Postal Service Health Benefits (PSHB) Improving Access to Workers' Compensation for Injured Federal Workers Act (H.R. 3170/S.3296) USPS Shipping Equity Act (H.R. 3011) One Big Beautiful Bill Act (H.R. 1) FAIR Fleets Act (H.R. 3098) Protect America's Workforce Act (H.R. 2550) Fair Pharmacies for Federal Employees Act (H.R. 4409) Equal COLA Act (H.R. 491/S.624) Tribal Labor Sovereignty Act (H.R. 1723/S.1301) Shutdown Fairness Act (H.R.7137/S.3168) Heat Workforce Standards Act of 2025 (H.R.6213) Pharmacists Fight Back (H.R.6610)

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1287, Fix FEDVIP Age Act H.R. 1597, Compassion for Vulnerable and Struggling Workers Act H.R. 1670, Family Building FEHB Fairness Act S. 797, The Family Building FEHB Fairness Act H.R. 2193, FEHB Protection Act of 2025 H.R. 4409, Fair Pharmacies for Federal Employees Act of 2025 H.R. 4648, Access to Fertility Treatment and Care Act S. 2408, Access to Fertility Treatment and Care Act H.R. 5127, PrEP and PEP are Prevention Act H.R. 6610, Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] H.R. 8731, Federal Employee Short-Term Disability Insurance Act of 2026 H.R. 9448, Federal Workforce Reproductive Rights Protection Act

Client expense: $340,000 · Firm income: Not reported

H.R. 2214, the Delinking Revenue from Unfair Gouging Act; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.Con.Res 14/S. Con. Res. 7, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R. 1, the One Big Beautiful Bill; Comments to FDA on "Re: Agency Information Collection Activities; Proposed Collection; Comment Request; Compounding Animal Drugs From Bulk Drug Substances [Docket No. FDA-2025-N-0082]"; LHHS Report Language Request to Improve the Care and Treatment of Long-Term Care Residents with Neuropsychiatric Symptoms; Comments to OMB on "Re: Request for Information: Deregulation"; Comments to HHS/DOGE on government efficiency, fraud, waste and PBMs; Comments on "Executive Order 14297 of May 12, 2025 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients"; Comments to CDC on "RE: June 25-26 Advisory Committee on Immunization Practices Meeting"; H.R.5316, the Drug Shortage Compounding and Patient Access Act; H.R.5256, the 340B ACCESS Act; Comments to FDA on "RE: Docket No. FDA-2025-N-2589, Comments on the Risks and Benefits of Menopause Hormone Therapy"; H.Res. 805, Recognizing October 2025 as American Pharmacists Month in honor of the contribution of pharmacists to provide safe, accessible, affordable, and beneficial patient care services and products to all residents and protect the public health of our communities; S.3345, the PBM Price Transparency and Accountability Act; H.R. 6609, Pharmacists Fight Back in Medicare and Medicaid Act; H.R. 6610, Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]; H.R. 6703, the Lower Health Care Premiums for All Americans Act; H.R.5133, the Patient's Right to Know Their Medication Act; H.R. 4409, the Fair Pharmacies for Federal Employees Act; S.3549/H.R.6837, the Fiduciary Accountability, Integrity and Reform (FAIR) Act; H.R.7148, the Consolidated Appropriations Act of 2026; Rural Health Transformation Program; Creation and Implementation of TrumpRx; Comments to FDA on RFI, "Re: Increasing Access to Nonprescription Drugs; Request for Information"; S.3822, Break up Big Medicine Act; Comments to FDA on RFT, "Re: [Docket No. FDA-2025-N-6743] - Scientific and Clinical Considerations for Testosterone Replacement Therapy (TRT) in Men with Hypogonadism"; Comments to DoL, HHS, and DoT regarding "Re: Transparency in Coverage Proposed Rule [CMS-9882-P]"; Pharmacy Shortage Areas in reference to USC-NCPA joint project Mapping Tool; H.R. 7895, the PBM Kickback Prohibition Act; Comments to FDA on their comment request "Re: Agency Information Collection Activities; Proposed Collection; Comment Request; Medication Guides for Prescription Drug Products [FDA-2025-N-6869]"; H.R.6509/S.3794, the SAFE Drug Act; H.R.5316, the Drug Shortage Compounding Patient Access Act; H.R.8779/S.4509, the Patients Before Monopolies Act; S.3788/H.R.8269, the CLEAR LABELS Act; S.1941, the Cure Hepatitis C Act of 2025;

S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3822; Break Up Big Medicine Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)

Client expense: $2,996,995 · Firm income: Not reported

S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2355/H.R. 5582; Patients Deserve Price Tags Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 1095; Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act S. 1096; Preserve Access to Affordable Generics and Biosimilars Act S. 1097; Interagency Patent Coordination and Improvements Act of 2025 S. 1414; Expedited Access to Biosimilars Act S. 2617; Reducing Drug Prices for Seniors Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S. 3349; PBM Disclosure Act S. 3549; PBM Fiduciary, Accountability, Integrity, and Reform Act S. 3822; Break Up Big Medicine Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4570; Interagency Patent Coordination and Improvements Act of 2025 H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 6837; To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services oSec. 6702- Full Rebate Pass Through to Plans H.R. 7895; PBM Kickback Prohibition Act H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)

Issues related to employer, small group and individual insurance markets. H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act H.R. 5433 - The Patients Over Profits Act S. 2836 - The Patients Over Profits Act H.R. 4409 - The Fair Pharmacies for Federal Employees Act of 2025 H.R. 6703, Lower Healthcare Premiums for All Americans Act H.R. 6610, The Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] S. 3822, Break Up Big Medicine Act

Client expense: $3,320,000 · Firm income: Not reported

H.R. 2214, the Delinking Revenue from Unfair Gouging Act; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.Con.Res 14/S. Con. Res. 7, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R. 1, the One Big Beautiful Bill; Comments to FDA on "Re: Agency Information Collection Activities; Proposed Collection; Comment Request; Compounding Animal Drugs From Bulk Drug Substances [Docket No. FDA-2025-N-0082]"; LHHS Report Language Request to Improve the Care and Treatment of Long-Term Care Residents with Neuropsychiatric Symptoms; Comments to OMB on "Re: Request for Information: Deregulation"; Comments to HHS/DOGE on government efficiency, fraud, waste and PBMs; Comments on "Executive Order 14297 of May 12, 2025 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients"; Comments to CDC on "RE: June 25-26 Advisory Committee on Immunization Practices Meeting"; H.R.5316, the Drug Shortage Compounding and Patient Access Act; H.R.5256, the 340B ACCESS Act; Comments to FDA on "RE: Docket No. FDA-2025-N-2589, Comments on the Risks and Benefits of Menopause Hormone Therapy"; H.Res. 805, Recognizing October 2025 as American Pharmacists Month in honor of the contribution of pharmacists to provide safe, accessible, affordable, and beneficial patient care services and products to all residents and protect the public health of our communities; S.3345, the PBM Price Transparency and Accountability Act; H.R. 6609, Pharmacists Fight Back in Medicare and Medicaid Act; H.R. 6610, Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]; H.R. 6703, the Lower Health Care Premiums for All Americans Act; H.R.5133, the Patient's Right to Know Their Medication Act; H.R. 4409, the Fair Pharmacies for Federal Employees Act; S.3549/H.R.6837, the Fiduciary Accountability, Integrity and Reform (FAIR) Act; H.R.7148, the Consolidated Appropriations Act of 2026; Rural Health Transformation Program; Creation and Implementation of TrumpRx; Comments to FDA on RFI, "Re: Increasing Access to Nonprescription Drugs; Request for Information"; S.3822, Break up Big Medicine Act; Comments to FDA on RFT, "Re: [Docket No. FDA-2025-N-6743] - Scientific and Clinical Considerations for Testosterone Replacement Therapy (TRT) in Men with Hypogonadism"; Comments to DoL, HHS, and DoT regarding "Re: Transparency in Coverage Proposed Rule [CMS-9882-P]"; Pharmacy Shortage Areas in reference to USC-NCPA joint project Mapping Tool; H.R. 7895, the PBM Kickback Prohibition Act; Comments to FDA on their comment request "Re: Agency Information Collection Activities; Proposed Collection; Comment Request; Medication Guides for Prescription Drug Products [FDA-2025-N-6869]";

S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2355/H.R. 5582; Patients Deserve Price Tags Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 1095; Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act S. 1096; Preserve Access to Affordable Generics and Biosimilars Act S. 1097; Interagency Patent Coordination and Improvements Act of 2025 S. 1414; Expedited Access to Biosimilars Act S. 2617; Reducing Drug Prices for Seniors Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S. 3349; PBM Disclosure Act S. 3549; PBM Fiduciary, Accountability, Integrity, and Reform Act S. 3822; Break Up Big Medicine Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4570; Interagency Patent Coordination and Improvements Act of 2025 H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 6837; To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services oSec. 6702- Full Rebate Pass Through to Plans H.R. 7895; PBM Kickback Prohibition Act H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)

S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3822; Break Up Big Medicine Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)

Client expense: $299,699 · Firm income: Not reported

Protect Our Letter Carriers Act (H.R. 1065/S. 463) Federal Retirement Fairness Act (H.R. 1522) Anti-privatization resolution (H.Res. 70/S.Res. 147) Postal Service retirement funds investment Postal Service Health Benefits (PSHB) Improving Access to Workers' Compensation for Injured Federal Workers Act (H.R. 3170/S.3296) USPS Shipping Equity Act (H.R. 3011) One Big Beautiful Bill Act (H.R. 1) FAIR Fleets Act (H.R. 3098) Protect America's Workforce Act (H.R. 2550) Fair Pharmacies for Federal Employees Act (H.R. 4409) Equal COLA Act (H.R. 491/S.624) Tribal Labor Sovereignty Act (H.R. 1723/S.1301) Shutdown Fairness Act (H.R.7137/S.3168)

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1287, Fix FEDVIP Age Act H.R. 1597, Compassion for Vulnerable and Struggling Workers Act H.R. 1670, Family Building FEHB Fairness Act S. 797, The Family Building FEHB Fairness Act H.R. 2193, FEHB Protection Act of 2025 H.R. 4409, Fair Pharmacies for Federal Employees Act of 2025 H.R. 4648, Access to Fertility Treatment and Care Act S. 2408, Access to Fertility Treatment and Care Act H.R. 5127, PrEP and PEP are Prevention Act H.R. 6610, Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]

Client expense: $310,000 · Firm income: Not reported

Issues related to employer, small group and individual insurance markets. H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act H.R. 5433 - The Patients Over Profits Act S. 2836 - The Patients Over Profits Act H.R. 4409 - The Fair Pharmacies for Federal Employees Act of 2025 H.R. 6703, Lower Healthcare Premiums for All Americans Act H.R. 6610, The Pharmacists Fight Back in Federal Health Benefits Plan Act

Client expense: $2,270,000 · Firm income: Not reported

Protect Our Letter Carriers Act (H.R. 1065/S. 463) Federal Retirement Fairness Act (H.R. 1522) Anti-privatization resolution (H.Res. 70/S.Res. 147) Postal Service retirement funds investment Postal Service Health Benefits (PSHB) Improving Access to Workers' Compensation for Injured Federal Workers Act (H.R. 3170) USPS Shipping Equity Act (H.R. 3011) One Big Beautiful Bill Act (H.R. 1) FAIR Fleets Act (H.R. 3098) Protect America's Workforce Act (H.R. 2550) Fair Pharmacies for Federal Employees Act (H.R. 4409) Equal COLA Act (H.R. 491/S.624) Tribal Labor Sovereignty Act (H.R. 1723/S.1301)

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1287, Fix FEDVIP Age Act H.R. 1597, Compassion for Vulnerable and Struggling Workers Act H.R. 1670, Family Building FEHB Fairness Act S. 797, The Family Building FEHB Fairness Act H.R. 2193, FEHB Protection Act of 2025 H.R. 4409, Fair Pharmacies for Federal Employees Act of 2025 H.R. 4648, Access to Fertility Treatment and Care Act S. 2408, Access to Fertility Treatment and Care Act H.R. 5127, PrEP and PEP are Prevention Act H.R. 6610, Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]

Client expense: $350,000 · Firm income: Not reported

Issues related to employer, small group and individual insurance markets. H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act P.L. 119-21 - The One Big, Beautiful Bill Act H.R. 5433 - The Patients Over Profits Act S. 2836 - The Patients Over Profits Act H.R. 4409 - The Fair Pharmacies for Federal Employees Act of 2025

Client expense: $2,150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Protect Our Letter Carriers Act (H.R. 1065/S. 463) Federal Retirement Fairness Act (H.R. 1522) Anti-privatization resolution (H.Res. 70/S.Res. 147) Postal Service retirement funds investment Postal Service Health Benefits (PSHB) Improving Access to Workers' Compensation for Injured Federal Workers Act (H.R. 3170) USPS Shipping Equity Act (H.R. 3011) One Big Beautiful Bill Act (H.R. 1) FAIR Fleets Act (H.R. 3098) Protect America's Workforce Act (H.R. 2550) Fair Pharmacies for Federal Employees Act (H.R. 4409)

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 882; Patients Before Middlemen Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act

Client expense: $2,948,162 · Firm income: Not reported

S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years

Client expense: $2,948,162 · Firm income: Not reported

S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act

Client expense: $2,948,162 · Firm income: Not reported

H.R. 1287, Fix FEDVIP Age Act H.R. 1597, Compassion for Vulnerable and Struggling Workers Act H.R. 1670, Family Building FEHB Fairness Act S. 797, The Family Building FEHB Fairness Act H.R. 2193, FEHB Protection Act of 2025 H.R. 4409, Fair Pharmacies for Federal Employees Act of 2025 H.R. 4648, Access to Fertility Treatment and Care Act S. 2408, Access to Fertility Treatment and Care Act H.R. 5127, PrEP and PEP are Prevention Act

Client expense: $300,000 · Firm income: Not reported